Caplin Point Laboratories shareholding pattern

CAPLIPOINT

1709

0.00 (0.00%)
Last updated on 30 Apr, 2026 | 15:52 IST
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Caplin Point Laboratories Shareholding Pattern

  • 2016-17
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

70.57%

Mutual Fund

2.02%

Insurance

0.01%

Foreign Institutional Investors

6.15%

Domestic Institutional Investors

0.11%

Retail

21.14%

Others

0%

Total Promoters
MAR '26
70.57%

Summary

For Year 2026-27, Caplin Point Laboratories reports the following shareholding: Total Promoters at 70.57%, Mutual Fund at 2.02%, Insurance at 0.01%, Foreign Institutional Investors at 6.15%, Domestic Institutional Investors at 0.11%, and Retail at 21.14%. This breakdown provides a quick snapshot of ownership distribution for Caplin Point Laboratories in 2026-27.

Caplin Point Laboratories FAQs

As of 05-2026, the promoter shareholding in Caplin Point Laboratories stands at 70.57% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.

The FII and DII shareholding of Caplin Point Laboratories is 6.15% and 0.11% respectively.

The retail shareholding of the Caplin Point Laboratories is 21.14%.

Changes in shareholding patterns of Caplin Point Laboratories can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.

Shareholding patterns of Caplin Point Laboratories are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.

The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost